NeuroPace Inc. (NPCE) NASDAQ
$8.51 (0.52) (-5.76%)
Market Cap: $259.78M
As of 05/16/24 03:59 PM EDT. Market closed.
NeuroPace Inc. (NPCE)
NASDAQ
$8.51
(0.52) (-5.76%)
Market Cap: $259.78M
As of 05/16/24 03:59 PM EDT. Market closed.
Add to Portfolio
the rns® system is an award-winning technology developed and manufactured in silicon valley that has been recognized for its innovation. similar to a pacemaker that monitors and responds to heart rhythms, the rns system is the world's first and only medical device that can monitor and respond to brain activity. neuropace was founded to design, develop, manufacture and market implantable devices ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
Full Time Employees
212
Address
.
PRICE CHART FOR NEUROPACE INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$9.06
Previous Close
$9.03
Days Range
$8.60 - $9.19
52 week range
$3.80 - $18.15
Volume
34,436
Avg. Volume (30 days)
120,676
Market Cap
$259.78M
Dividend Yield
-
P/E
(8.25)
Shares Outstanding
28,768,128
Open
$9.06
Previous Close
$9.03
Days Range
$8.60 - $9.19
52 week range
$3.80 - $18.15
Volume
34,436
Avg. Volume (30 days)
120,676
Market Cap
$259.78M
Dividend Yield
-
P/E
(8.25)
Shares Outstanding
28,768,128
FINANCIAL STATEMENTS FOR NEUROPACE INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR NEUROPACE INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| ORBIMED ADVISORS LLC | 10% Owner | May 03, 2024 | Sale | $14.03 | 4,674 | 65,576 | 3,406,335 | May 03, 2024, 05:16 PM |
| ORBIMED ADVISORS LLC | 10% Owner | May 02, 2024 | Sale | $14.01 | 8,842 | 123,876 | 3,411,009 | May 03, 2024, 05:16 PM |
| ORBIMED ADVISORS LLC | 10% Owner | May 01, 2024 | Sale | $14.02 | 15,690 | 219,974 | 3,419,851 | May 03, 2024, 05:16 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Apr 24, 2024 | Sale | $14.06 | 1,781 | 25,041 | 3,435,541 | Apr 26, 2024, 05:01 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Apr 23, 2024 | Sale | $14.29 | 21,791 | 311,393 | 3,437,322 | Apr 23, 2024, 06:38 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Apr 22, 2024 | Sale | $14.05 | 24,609 | 345,756 | 3,459,113 | Apr 23, 2024, 06:38 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Apr 19, 2024 | Sale | $14.02 | 18,253 | 255,907 | 3,483,722 | Apr 23, 2024, 06:38 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Apr 16, 2024 | Sale | $14.01 | 14,069 | 197,107 | 3,504,898 | Apr 18, 2024, 05:10 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Apr 18, 2024 | Sale | $14.06 | 2,623 | 36,879 | 3,501,975 | Apr 18, 2024, 05:10 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Apr 17, 2024 | Sale | $14.15 | 300 | 4,245 | 3,504,598 | Apr 18, 2024, 05:10 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Apr 12, 2024 | Sale | $14.42 | 23,101 | 333,116 | 3,518,967 | Apr 15, 2024, 05:25 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Apr 11, 2024 | Sale | $14.49 | 461,899 | 6,692,916 | 3,542,068 | Apr 15, 2024, 05:25 PM |
| Morrell Martha | Chief Medical Officer | Feb 05, 2024 | Sale | $15.17 | 3,446 | 52,278 | 77,762 | Feb 06, 2024, 07:16 PM |
| Morrell Martha | Chief Medical Officer | Feb 02, 2024 | Sale | $15.07 | 14,143 | 213,122 | 81,208 | Feb 06, 2024, 07:16 PM |
| Morrell Martha | Chief Medical Officer | Jan 30, 2024 | Sale | $15.10 | 11,262 | 170,004 | 97,937 | Feb 01, 2024, 09:47 PM |
| Morrell Martha | Chief Medical Officer | Feb 01, 2024 | Sale | $15.04 | 663 | 9,971 | 95,351 | Feb 01, 2024, 09:47 PM |
| Morrell Martha | Chief Medical Officer | Jan 31, 2024 | Sale | $15.08 | 1,923 | 28,990 | 96,014 | Feb 01, 2024, 09:47 PM |
| Morrell Martha | Chief Medical Officer | Jan 25, 2024 | Sale | $15.00 | 1 | 15 | 109,199 | Jan 26, 2024, 06:04 PM |
| Morrell Martha | Chief Medical Officer | Jan 24, 2024 | Sale | $15.02 | 827 | 12,426 | 109,200 | Jan 26, 2024, 06:04 PM |
| Morrell Martha | Chief Medical Officer | Dec 27, 2023 | Sale | $10.12 | 13,300 | 134,648 | 110,027 | Dec 28, 2023, 05:47 PM |
| Morrell Martha | Chief Medical Officer | Dec 26, 2023 | Sale | $10.00 | 102 | 1,020 | 123,327 | Dec 28, 2023, 05:47 PM |
| Morrell Martha | Chief Medical Officer | Dec 20, 2023 | Sale | $10.14 | 2,730 | 27,695 | 123,429 | Dec 22, 2023, 04:21 PM |
| Morrell Martha | Chief Medical Officer | Dec 06, 2023 | Sale | $8.16 | 11,005 | 89,773 | 126,159 | Dec 07, 2023, 04:07 PM |
| KCK LTD. | 10% Owner | Dec 01, 2023 | Sale | $8.73 | 3,241 | 28,294 | 5,593,773 | Dec 01, 2023, 09:57 PM |
| KCK LTD. | 10% Owner | Nov 30, 2023 | Sale | $8.84 | 7,282 | 64,373 | 5,597,014 | Dec 01, 2023, 09:57 PM |
| KCK LTD. | 10% Owner | Nov 29, 2023 | Sale | $8.72 | 5,644 | 49,216 | 5,604,296 | Dec 01, 2023, 09:57 PM |
| KCK LTD. | 10% Owner | Nov 28, 2023 | Sale | $8.75 | 4,681 | 40,959 | 5,609,940 | Nov 29, 2023, 05:35 PM |
| KCK LTD. | 10% Owner | Nov 27, 2023 | Sale | $8.96 | 6,490 | 58,150 | 5,614,621 | Nov 29, 2023, 05:35 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Oct 02, 2023 | Sale | $9.08 | 7,614 | 69,135 | 4,004,667 | Oct 04, 2023, 05:36 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Oct 03, 2023 | Sale | $9.02 | 700 | 6,314 | 4,003,967 | Oct 04, 2023, 05:36 PM |
| Accelmed Partners II L.P. | 10% Owner | Nov 22, 2022 | Buy | $1.50 | 62,398 | 93,535 | 4,432,948 | Nov 23, 2022, 05:29 PM |
| Accelmed Partners II L.P. | 10% Owner | Nov 21, 2022 | Buy | $1.50 | 327,893 | 491,512 | 4,370,550 | Nov 23, 2022, 05:29 PM |
| Kuhn Rebecca | Chief Financial Officer | Oct 31, 2022 | Option Exercise | $0.03 | 1,428 | 37 | 59,704 | Nov 02, 2022, 09:18 PM |
| LACOB JOSEPH | Director | Oct 18, 2022 | Option Exercise | $0.03 | 192 | 5 | 384 | Oct 20, 2022, 07:57 PM |
| Morrell Martha | Chief Medical Officer | Oct 07, 2022 | Option Exercise | $0.03 | 576 | 15 | 57,164 | Oct 11, 2022, 04:09 PM |
| Ridley Irina | General Counsel and Secretary | Jun 08, 2022 | Sale | $5.78 | 2,500 | 14,445 | 61,139 | Jun 09, 2022, 07:47 PM |
| Ridley Irina | General Counsel and Secretary | Feb 28, 2022 | Sale | $7.54 | 1,470 | 11,082 | 6,652 | Mar 01, 2022, 07:35 PM |
| Ridley Irina | General Counsel and Secretary | Apr 21, 2021 | Buy | $17.00 | 2,352 | 39,984 | 2,352 | Apr 23, 2021, 07:58 PM |
| Accelmed Partners II L.P. | 10% Owner | Apr 21, 2021 | Buy | $17.00 | 588,235 | 9,999,995 | 588,235 | Apr 23, 2021, 07:44 PM |
| Fischer Frank M | Director | Apr 21, 2021 | Buy | $17.00 | 50,000 | 850,000 | 93,291 | Apr 23, 2021, 07:43 PM |
| Garfield Greg Shaw | Director | Apr 21, 2021 | Buy | $17.00 | 13,235 | 224,995 | 38,853 | Apr 23, 2021, 07:27 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| ORBIMED ADVISORS LLC | 10% Owner | 05/03/2024 | 65,576 |
| ORBIMED ADVISORS LLC | 10% Owner | 05/02/2024 | 123,876 |
| ORBIMED ADVISORS LLC | 10% Owner | 05/01/2024 | 219,974 |
| ORBIMED ADVISORS LLC | 10% Owner | 04/24/2024 | 25,041 |
| ORBIMED ADVISORS LLC | 10% Owner | 04/23/2024 | 311,393 |
| ORBIMED ADVISORS LLC | 10% Owner | 04/22/2024 | 345,756 |
| ORBIMED ADVISORS LLC | 10% Owner | 04/19/2024 | 255,907 |
| ORBIMED ADVISORS LLC | 10% Owner | 04/16/2024 | 197,107 |
| ORBIMED ADVISORS LLC | 10% Owner | 04/18/2024 | 36,879 |
| ORBIMED ADVISORS LLC | 10% Owner | 04/17/2024 | 4,245 |
| ORBIMED ADVISORS LLC | 10% Owner | 04/12/2024 | 333,116 |
| ORBIMED ADVISORS LLC | 10% Owner | 04/11/2024 | 6,692,916 |
| Morrell Martha | Chief Medical Officer | 02/05/2024 | 52,278 |
| Morrell Martha | Chief Medical Officer | 02/02/2024 | 213,122 |
| Morrell Martha | Chief Medical Officer | 01/30/2024 | 170,004 |
| Morrell Martha | Chief Medical Officer | 02/01/2024 | 9,971 |
| Morrell Martha | Chief Medical Officer | 01/31/2024 | 28,990 |
| Morrell Martha | Chief Medical Officer | 01/25/2024 | 15 |
| Morrell Martha | Chief Medical Officer | 01/24/2024 | 12,426 |
| Morrell Martha | Chief Medical Officer | 12/27/2023 | 134,648 |
| Morrell Martha | Chief Medical Officer | 12/26/2023 | 1,020 |
| Morrell Martha | Chief Medical Officer | 12/20/2023 | 27,695 |
| Morrell Martha | Chief Medical Officer | 12/06/2023 | 89,773 |
| KCK LTD. | 10% Owner | 12/01/2023 | 28,294 |
| KCK LTD. | 10% Owner | 11/30/2023 | 64,373 |
| KCK LTD. | 10% Owner | 11/29/2023 | 49,216 |
| KCK LTD. | 10% Owner | 11/28/2023 | 40,959 |
| KCK LTD. | 10% Owner | 11/27/2023 | 58,150 |
| ORBIMED ADVISORS LLC | 10% Owner | 10/02/2023 | 69,135 |
| ORBIMED ADVISORS LLC | 10% Owner | 10/03/2023 | 6,314 |
| Accelmed Partners II L.P. | 10% Owner | 11/22/2022 | 93,535 |
| Accelmed Partners II L.P. | 10% Owner | 11/21/2022 | 491,512 |
| Kuhn Rebecca | Chief Financial Officer | 10/31/2022 | 37 |
| LACOB JOSEPH | Director | 10/18/2022 | 5 |
| Morrell Martha | Chief Medical Officer | 10/07/2022 | 15 |
| Ridley Irina | General Counsel and Secretary | 06/08/2022 | 14,445 |
| Ridley Irina | General Counsel and Secretary | 02/28/2022 | 11,082 |
| Ridley Irina | General Counsel and Secretary | 04/21/2021 | 39,984 |
| Accelmed Partners II L.P. | 10% Owner | 04/21/2021 | 9,999,995 |
| Fischer Frank M | Director | 04/21/2021 | 850,000 |
| Garfield Greg Shaw | Director | 04/21/2021 | 224,995 |
Load More Insider Transactions
FUNDS WITH A POSITION IN NEUROPACE INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 3,406,335 | 0.88% | -14.93% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 119,971 | 0.00249% | 10.75% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 116,960 | 0.00014% | 0.83% | Other |
| BLACKROCK INC. | 74,154 | 0.00002% | -14.27% | Other |
| BALYASNY ASSET MANAGEMENT L.P. | 26,950 | 0.00062% | -0.76% | Event Driven |
CHANGE IN SHARES OUTSTANDING FOR NEUROPACE INC
STOCK BUYBACKS FOR NEUROPACE INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
5.50%
1Q
09/30/2023
8.72%
2Q
06/30/2023
11.04%
3Q
03/31/2023
12.70%
4Q
12/31/2022
13.89%
5Q
09/30/2022
14.38%
6Q
06/30/2022
15.43%
7Q
03/31/2022
16.36%
8Q
12/31/2021
70.30%
9Q
09/30/2021
17.36%
10Q
06/30/2021
61.13%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR NEUROPACE INC
LOADING...